Pharmaceutical company
Issues related to biosimilars, generally
Issues related to drug pricing and value, generally
Issues related to the importation of prescription medicines
Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), generally Medicare Part B coverage and reimbursement issues
Issues related to Medicare Part D
Coding and reimbursement for oncology drugs/biologics/biosimilars
Issues relating to the 340B Drug Pricing Program
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
STEVEN E IRIZARRY VINCENT A. ROBERTI, SR. STEVEN E IRIZARRY VINCENT A. ROBERTI, SR.